Skip header and navigation

Refine By

123 records – page 1 of 13.

2011 Canadian Hypertension Education Program recommendations: an annual update.

https://arctichealth.org/en/permalink/ahliterature128763
Source
Can Fam Physician. 2011 Dec;57(12):1393-7
Publication Type
Article
Date
Dec-2011
Author
Norm Campbell
Source
Can Fam Physician. 2011 Dec;57(12):1393-7
Date
Dec-2011
Language
English
Publication Type
Article
Keywords
Angiotensin Receptor Antagonists - therapeutic use
Canada
Diabetes Complications - complications
Diabetes Mellitus - drug therapy
Health education
Health Policy
Humans
Hypertension - complications - drug therapy - prevention & control
Life Style
Risk factors
Stroke - complications
Notes
Cites: Eur Heart J. 2001 Aug;22(15):1343-5211465967
Cites: Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):519-2320195154
Cites: Stroke. 2002 May;33(5):1315-2011988609
Cites: Can J Cardiol. 2002 Jun;18(6):657-6112107423
Cites: J Hypertens. 2004 Jan;22(1):11-915106785
Cites: Arch Neurol. 1993 Aug;50(8):855-628352673
Cites: Fam Pract. 1997 Apr;14(2):160-769137956
Cites: Am J Hypertens. 1997 Oct;10(10 Pt 1):1097-1029370379
Cites: Arch Intern Med. 2005 Jun 27;165(12):1410-915983291
Cites: Can J Cardiol. 2007 May 1;23(6):437-4317487286
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: Can J Cardiol. 2007 Dec;23(14):1124-3018060097
Cites: Circulation. 2008 Feb 12;117(6):743-5318212285
Cites: Lancet Neurol. 2008 May;7(5):391-918396107
Cites: Can J Cardiol. 2008 Jun;24(6):483-418548145
Cites: Can J Cardiol. 2008 Jun;24(6):485-9018548146
Cites: Can J Cardiol. 2008 Jun;24(6):497-118548148
Cites: Am J Hypertens. 2008 Nov;21(11):1210-518772857
Cites: Hypertension. 2009 Feb;53(2):128-3419114646
Cites: Can J Cardiol. 2009 May;25(5):279-8619417858
Cites: Can J Cardiol. 2009 May;25(5):299-30219417860
Cites: Eur Heart J. 2009 Jun;30(12):1434-919454575
Cites: J Hypertens. 2009 Jul;27(7):1472-719474763
Cites: Can J Cardiol. 2009 Aug;25(8):451-219668778
Cites: Arch Intern Med. 2009 Nov 23;169(21):1996-200219933962
Cites: Pharmacotherapy. 2010 Mar;30(3):228-3520180606
Cites: Health Rep. 2010 Mar;21(1):37-4620426225
Cites: N Engl J Med. 2010 Apr 29;362(17):1575-8520228401
Cites: Int J Stroke. 2010 Apr;5(2):110-620446945
Cites: Curr Opin Cardiol. 2010 Jul;25(4):366-7220502323
Cites: JAMA. 2002 Feb 27;287(8):1003-1011866648
PubMed ID
22170191 View in PubMed
Less detail

Activism for medical geographers: American, British and Canadian viewpoints.

https://arctichealth.org/en/permalink/ahliterature103469
Source
Soc Sci Med. 1990;30(1):173-7
Publication Type
Article
Date
1990
Author
M R Greenberg
M W Rosenberg
D R Phillips
D. Schneider
Author Affiliation
Department of Urban Studies and Community Health, Rutgers University, New Brunswick, NJ 08903.
Source
Soc Sci Med. 1990;30(1):173-7
Date
1990
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Canada
Consumer Advocacy
Educational Status
Great Britain
Health Education - methods
Health planning
Health Policy
Humans
Minority Groups
Research
Risk factors
Socioeconomic Factors
United States
Abstract
This paper describes some of our personal efforts to launch research projects that address public health issues of interest to geographers in the United States, Canada and Britain. In pressing these agendas we have found through our experiences that there are personal and disciplinary costs associated with activism. We describe the loss of identity with geography; the frustration of trying to persuade bench scientists, corporate representatives, and government officials of the importance of our work; the loss of research time and contact with both our academic colleagues and students.
PubMed ID
2305280 View in PubMed
Less detail

Adolescent smoking and exposure to tobacco marketing under a tobacco advertising ban: Findings from 2 Norwegian national samples

https://arctichealth.org/en/permalink/ahliterature67227
Source
American Journal of Public Health. 2004 Jul;94(7):1230-1238
Publication Type
Article
Date
Jul-2004
  1 website  
Author
Braverman, MT
Aarø, LE
Author Affiliation
Department of Human and Community Development, University of California, Davis 95616, USA. mtbraverman@ucdavis.edu
Source
American Journal of Public Health. 2004 Jul;94(7):1230-1238
Date
Jul-2004
Language
English
Geographic Location
Norway
Publication Type
Article
Keywords
Adolescent
Adolescent Behavior - psychology
Adolescent Psychology - statistics & numerical data
Advertising - legislation & jurisprudence - methods - statistics & numerical data
Attitude to Health
Cohort Studies
Female
Friends - psychology
Habits
Health Knowledge, Attitudes, Practice
Health Policy - legislation & jurisprudence
Health Surveys
Humans
Logistic Models
Male
Marketing - organization & administration
Mass Media
Multivariate Analysis
Needs Assessment
Norway - epidemiology
Peer Group
Questionnaires
Risk factors
Smoking - epidemiology - prevention & control - psychology
Tobacco Industry - organization & administration
Abstract
OBJECTIVES: We examined the extent to which adolescents in Norway have been exposed to tobacco marketing despite an existing ban, and whether exposure is related to their current smoking or expectations they will smoke in the future. METHODS: Questionnaires were administered to nationally representative systematic samples of Norwegian youths aged 13 to 15 years in 1990 (n = 4282) and 1995 (n = 4065). RESULTS: About half in each cohort reported exposure to marketing. Youths reporting exposure were significantly more likely to be current smokers and to expect to be smokers at 20 years of age, after control for important social influence predictors. CONCLUSIONS: Adolescents' current smoking and future smoking expectations are linked to marketing exposure even in limited settings, suggesting the need for comprehensive controls to eliminate the function of marketing in promoting adolescent smoking.
PubMed ID
15226148 View in PubMed
Online Resources
Less detail

[A gap in the welfare. Every other low-income earner skips visits to the dentist--a public health problem is to be expected]

https://arctichealth.org/en/permalink/ahliterature75749
Source
Lakartidningen. 2006 Mar 8-14;103(10):738-9
Publication Type
Article
Author
Björn Klinge
Author Affiliation
Karolinska institutet, Stockholm. Bjorn.Klinge@ki.se
Source
Lakartidningen. 2006 Mar 8-14;103(10):738-9
Language
Swedish
Publication Type
Article
Keywords
Dental Health Services - economics
Dental Prophylaxis - economics
Health Policy - economics
Humans
Income
Oral Health
Risk factors
Socioeconomic Factors
Sweden
PubMed ID
16610199 View in PubMed
Less detail
Source
CMAJ. 1993 Aug 1;149(3):265, 268; author reply 268-9
Publication Type
Article
Date
Aug-1-1993
Author
F W Danby
Source
CMAJ. 1993 Aug 1;149(3):265, 268; author reply 268-9
Date
Aug-1-1993
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - epidemiology - prevention & control - transmission
Canada
Health Policy
Humans
Mass Screening
Risk factors
Notes
Comment On: CMAJ. 1993 Mar 1;148(5):802-58439940
PubMed ID
8339169 View in PubMed
Less detail
Source
CMAJ. 1993 Aug 1;149(3):265; author reply 268-9
Publication Type
Article
Date
Aug-1-1993
Author
J E Parker
Source
CMAJ. 1993 Aug 1;149(3):265; author reply 268-9
Date
Aug-1-1993
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - prevention & control - transmission
British Columbia
Health Policy
Humans
Risk factors
Notes
Comment On: CMAJ. 1993 Mar 1;148(5):802-58439940
PubMed ID
8339168 View in PubMed
Less detail

Alcohol in Canada: reducing the toll through focused interventions and public health policies.

https://arctichealth.org/en/permalink/ahliterature136996
Source
CMAJ. 2011 Mar 8;183(4):450-5
Publication Type
Article
Date
Mar-8-2011
Author
Norman Giesbrecht
Timothy Stockwell
Perry Kendall
Robert Strang
Gerald Thomas
Author Affiliation
Social and Epidemiological Research Department, Centre for Addiction and Mental Health, Toronto, Ont. norman_giesbrecht@camh.net
Source
CMAJ. 2011 Mar 8;183(4):450-5
Date
Mar-8-2011
Language
English
Publication Type
Article
Keywords
Alcohol-Related Disorders - epidemiology - prevention & control
Canada - epidemiology
Evidence-Based Medicine
Health Policy
Health Promotion - organization & administration
Humans
Public Health
Risk factors
Notes
Cites: J Stud Alcohol Drugs. 2007 May;68(3):345-5217446973
Cites: Addiction. 2007 Sep;102(9):1345-917645431
Cites: Addiction. 2009 Feb;104(2):179-9019149811
Cites: Drug Alcohol Rev. 2009 May;28(3):301-2319489992
Cites: Lancet. 2009 Jun 27;373(9682):2223-3319560604
Cites: MMWR Morb Mortal Wkly Rep. 2010 Oct 8;59(39):1274-920930706
Cites: Lancet. 2009 Jun 27;373(9682):2247-5719560606
Cites: Alcohol Alcohol. 2009 Sep-Oct;44(5):500-1619734159
Cites: Addiction. 2009 Nov;104(11):1827-3619681801
Cites: Addiction. 2009 Dec;104(12):2023-3219922569
Cites: Addiction. 2010 Aug;105(8):1323-520653610
Cites: Lancet. 2009 Jun 27;373(9682):2234-4619560605
PubMed ID
21324848 View in PubMed
Less detail

Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines.

https://arctichealth.org/en/permalink/ahliterature184450
Source
Am J Manag Care. 2003 Jul;9(7):477-89
Publication Type
Article
Date
Jul-2003
Author
Jaime Caro
Krista F Huybrechts
Wendy S Klittich
Joseph D Jackson
Alistair McGuire
Author Affiliation
Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA. jcaro@caroresearch.com
Source
Am J Manag Care. 2003 Jul;9(7):477-89
Date
Jul-2003
Language
English
Publication Type
Article
Keywords
Adult
Anticholesteremic Agents - economics - therapeutic use
Canada
Cardiovascular Diseases - drug therapy - economics - prevention & control
Cost Savings
Cost of Illness
Female
Health Care Rationing
Health Expenditures
Health Policy
Health Services Research
Health Status Indicators
Humans
Male
Practice Guidelines as Topic
Pravastatin - economics - therapeutic use
Preventive Health Services - economics
Quality-Adjusted Life Years
Risk factors
Abstract
Controversy persists about the most efficient allocation of healthcare funds for cardiovascular disease prevention. Previous economic analyses have generally focused on primary or secondary prevention as discrete categories.
To address the information required by decision-makers to distribute budgets optimally across an entire population at risk in view of recommendations promulgated by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III).
The Continuum of Risk Evaluation (CORE) model is an individual patient simulation of the occurrence of cardiovascular disease allowing for analyses over a broad range of risk. All events are tallied, costs are applied, and survival is modified accordingly. Disaggregated presentation of the results allows decision-makers to evaluate the budgetary implications and cost effectiveness of different strategies according to the risk at which treatment is initiated. This process is illustrated for the United States using information from the 1988-1994 National Health and Nutrition Examination Survey and pravastatin trials.
Secondary prevention with pravastatin costs dollar 2900 per life-year gained for men and dollar 1100 per life-year gained for women. Lowering the treatment threshold to incorporate primary prevention yields cost-effectiveness ratios that remain below dollar 25 000 per undiscounted life-year gained until a 10-year cardiovascular disease risk of 14.4%. Cost savings are possible for very high-risk patients.
The economic impact of an integrated approach to prevention of cardiovascular disease has not been thoroughly explored. CORE permits realistic analysis of policy decisions involving the entire continuum of risk rather than isolated consideration of specific disease stages, and thus provides a unique tool for assessing the full implications of treatment guidelines such as those of the NCEP ATP III.
PubMed ID
12866627 View in PubMed
Less detail

The ambiguity of ethnicity as risk factor of vitamin D deficiency--a case study of Danish vitamin D policy documents.

https://arctichealth.org/en/permalink/ahliterature133691
Source
Health Policy. 2011 Sep;102(1):56-63
Publication Type
Article
Date
Sep-2011
Author
Anna Mygind
Janine Morgall Traulsen
Lotte Stig Nørgaard
Paul Bissell
Author Affiliation
Department of Social Pharmacy, Institute of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100, Copenhagen Ø, Denmark. am@farma.ku.dk
Source
Health Policy. 2011 Sep;102(1):56-63
Date
Sep-2011
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Age Factors
Culture
Denmark - epidemiology
Emigrants and Immigrants
Ethnic Groups - statistics & numerical data
Female
Health Policy
Humans
Islam
Male
Minority Groups - statistics & numerical data
Policy Making
Risk factors
Sex Factors
Skin pigmentation
Vitamin D Deficiency - epidemiology - ethnology - genetics
Abstract
To explore how ethnic minorities at risk of vitamin D deficiency are constructed in Danish policy documents (current as of April 2009), regarding vitamin D supplementation.
Ten policy documents were analysed through content analysis, focusing on definitions and explanations of ethnic minorities being at risk of vitamin D deficiency. This formed the basis for an analysis of constructions of ethnic minorities at risk which was undertaken using the Social Construction of Technology (SCOT) theory as an organising framework.
The analysis showed a high degree of interpretative flexibility regarding how ethnic minorities are constructed as a risk group for vitamin D deficiency. The ten documents analysed revealed eight different constructions of the ethnic minorities groups at risk. A low degree of interpretative flexibility was found regarding the importance of skin colour and skin covering. Major disagreements were found regarding the importance attributed to the Islamic religion, other traditions, immigration, gender and age, and use of an evolutionary explanation for the increased risk.
Ethnic minorities at risk of vitamin D deficiency are constructed very differently in Danish policies current as of April 2009. A more precise definition of ethnic minorities in policies and research may be helpful in seeking to identify which ethnic minorities are and are not at risk of vitamin D deficiency.
PubMed ID
21676481 View in PubMed
Less detail

123 records – page 1 of 13.